Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005550602
Thu, 27.07.2023
Drägerwerk AG & Co. KGaA
Dräger with significant increase in net sales and earnings in the first half of 2023
Net sales increase of around 20 percent compared to the prior-year period
Noticeable improvement in delivery capabilities
Net sales growth across both segments and all regions
EBIT well up at around EUR 48 million
Order intake slightly below high prior-year le [ … ]
Thu, 27.07.2023
Drägerwerk AG & Co. KGaA
Dräger with significant increase in net sales and earnings in the first half of 2023
Net sales increase of around 20 percent compared to the prior-year period
Noticeable improvement in delivery capabilities
Net sales growth across both segments and all regions
EBIT well up at around EUR 48 million
Order intake slightly below high prior-year le [ … ]
Fri, 14.07.2023
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed
Lübeck, July 14, 2023 – Dräger's net sales in the first half of 2023 increased by 19.6 percent (net of currency effects; nominal: 17.7 percent) t [ … ]
Fri, 14.07.2023
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed
Lübeck, July 14, 2023 – Dräger's net sales in the first half of 2023 increased by 19.6 percent (net of currency effects; nominal: 17.7 percent) t [ … ]
Fri, 05.05.2023
Drägerwerk AG & Co. KGaA
Due to an editorial error, the German version of the ad-hoc notification dated April 17, 2023 on the preliminary financial figures for the first quarter 2023 incorrectly stated the Group order intake for the prior-year quarter in "Mrd." (billion) instead of "Mio." (million): Order intake "3 Monate 2022" (3 months 2022) was erroneously stated as "82 [ … ]
Fri, 05.05.2023
Drägerwerk AG & Co. KGaA
Due to an editorial error, the German version of the ad-hoc notification dated April 17, 2023 on the preliminary financial figures for the first quarter 2023 incorrectly stated the Group order intake for the prior-year quarter in "Mrd." (billion) instead of "Mio." (million): Order intake "3 Monate 2022" (3 months 2022) was erroneously stated as "82 [ … ]
Fri, 05.05.2023
Drägerwerk AG & Co. KGaA
Dräger's Annual General Meeting approves stable dividend for fiscal year 2022
Lübeck—Drägerwerk AG & Co. KGaA held its Annual General Meeting 2023 today. All resolutions on the agenda items were passed with a vast majority. In total, 45.7 percent of the share capital was represented (2022: 46.5 percent).
Dividend
Among the agenda items was th [ … ]
Fri, 05.05.2023
Drägerwerk AG & Co. KGaA
Dräger's Annual General Meeting approves stable dividend for fiscal year 2022
Lübeck—Drägerwerk AG & Co. KGaA held its Annual General Meeting 2023 today. All resolutions on the agenda items were passed with a vast majority. In total, 45.7 percent of the share capital was represented (2022: 46.5 percent).
Dividend
Among the agenda items was th [ … ]
Fri, 28.04.2023
Drägerwerk AG & Co. KGaA
Dräger with strong net sales growth and positive earnings in the first quarter of 2023
Net sales increase of 18 percent compared to the same quarter in the previous year
Net sales growth across both divisions and all regions
EBIT well up at around EUR 29 million
Noticeable improvement in supply capability as well as temporarily high demand for [ … ]
Fri, 28.04.2023
Drägerwerk AG & Co. KGaA
Dräger with strong net sales growth and positive earnings in the first quarter of 2023
Net sales increase of 18 percent compared to the same quarter in the previous year
Net sales growth across both divisions and all regions
EBIT well up at around EUR 29 million
Noticeable improvement in supply capability as well as temporarily high demand for [ … ]